CXCL8 and treatment resistant depression: Assessing IL-8 concentrations in serum or cerebrospinal fluid across various subtypes of TRD could reveal whether specific inflammatory profiles correlate with resistance to certain treatments, such as pharmacotherapy, electroconvulsive therapy, or novel biological interventions.